- 我們的平颱 What is G2H
- 科學原理 The Science of Polygenic Scoring
- 示例報告Sample Report
- 關於遺傳檢測 More about Genetic Testing
- 常見問題 FAQ
- 産品信息 Product Info
- 公司信息 Company Info
- 服務內容 All services
- 使用諮詢 Consult before use
- 售後服務 Customer service
- 遺傳諮詢 Genetic counselling
- 臨床諮詢 Clinical counselling
- AI 虛擬諮詢師 AI virtual counselling
- 近期活動 Recent activities
- 我們的平颱 What is G2H
- 科學原理 The Science of Polygenic Scoring
- 示例報告Sample Report
- 關於遺傳檢測 More about Genetic Testing
- 常見問題 FAQ
- 産品信息 Product Info
- 公司信息 Company Info
- 服務內容 All services
- 使用諮詢 Consult before use
- 售後服務 Customer service
- 遺傳諮詢 Genetic counselling
- 臨床諮詢 Clinical counselling
- AI 虛擬諮詢師 AI virtual counselling
- 近期活動 Recent activities
Polygenic Risk Scores: Technology, Applications, and Potential in Predicting Health Traits and Disease Risk
- 2023-07-27 19:20:00
- unfated 原創
- 1826
Introduction
Genetics plays an integral role in determining an individual's susceptibility to various diseases. Advances in genomic technology have enabled scientists to explore the genetic architecture of complex traits and diseases. Among these developments, Polygenic Risk Scores (PRS) have emerged as a significant technological breakthrough, leveraging genome-wide association studies (GWAS) data to calculate an individual's cumulative risk across many genetic variants.
The Technology behind Polygenic Risk Scores
The computation of PRS is based on GWAS, which is a study of a genome-wide set of genetic variants in different individuals to see if any variant is associated with a trait. GWAS identify single nucleotide polymorphisms (SNPs) that are correlated with the traits of interest. Following a GWAS, a PRS can be computed for an individual as the sum of risk alleles that the person has, each weighted by the effect size estimated from the GWAS.
Essentially, PRS takes into account the additive effects of multiple genetic variants, considering not only those with a large impact but also those with a small effect. This polygenic approach helps capture a broader view of genetic predisposition, thereby providing a more comprehensive risk profile.
Applications of Polygenic Risk Scores
PRS are currently being used in a variety of contexts, from academic research to clinical settings. They are often applied to predict individual risk for diseases that have a known genetic component, such as breast cancer, coronary artery disease, and type 2 diabetes.
In the research context, PRS are helping scientists to understand the genetics behind complex traits and diseases better. This increased understanding is also facilitating the development of potential new treatments and interventions.
In clinical settings, PRS are increasingly being integrated into risk assessment models to provide a more personalized estimate of disease risk. This can assist clinicians in identifying high-risk individuals for earlier interventions or more intensive monitoring.
Potential of PRS in Predicting Health Traits and Disease Risk
The potential of PRS is vast. They offer the possibility of screening an entire population for genetic risk factors, thus identifying at-risk individuals even before the onset of symptoms. This can open up new pathways for preventive medicine and early intervention, which could significantly impact public health.
Moreover, the potential of PRS goes beyond just disease risk prediction. They could also be used to predict other health-related traits such as height, body mass index (BMI), or even complex traits like educational attainment or personality traits.
Conclusion
Despite the promising potential of PRS, there are still limitations and challenges that need to be addressed. These include the issue of bias towards populations of European ancestry in GWAS studies and the ethical implications of genetic risk prediction. Nevertheless, as we continue to refine this technology and address these challenges, PRS hold the promise of revolutionizing personalized healthcare by providing an individualized genetic risk profile. They offer an exciting frontier in our ongoing exploration of the human genome and its impact on health and disease.
我們是來自香港大學醫學院的博士創業糰隊,擁有以Polygenic Scoring (多基因風險評分,PGS)的核心技術,基因智健(G2H)是我們開髮的首款産品。該平颱主要利用基於PGS的統計機器學習模型分析用戶DNA數據,從而預測和評估數百種人類疾病風險和健康錶型,爲您的健康人生保駕護航。
聯繫人: | Dr. CHEN Guolan Lane |
---|---|
電話: | +852 46404365 |
Email: | support@gene2h.com |
QQ: | 3028035047 |
微信: | lanechenhku |
微博: | u/7735987435 |
地址: | 1)中國香港特彆行政區薄扶林沙宣道5號1F; 2)中國廣東省廣州市黃埔區(廣州開髮區)科豐路91號903 |
掃一掃企業微信客服,立卽與我們溝通